We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

Medication Removal and Research in Psychotic Disorders—Reply

William T. Carpenter, MD; Nina R. Schooler, MD; John M. Kane, MD
Arch Gen Psychiatry. 1998;55(3):283. doi:.
Text Size: A A A
Published online


In reply

We appreciate the thoughtful attention that our article has received from Drs Baldessarini and Viguera and from Dr Volavka. They provide information that is important for investigators to consider when determining the optimal compromise among the scientific requirements of protocol design, clinical considerations, financial considerations, and general burden to patient subjects. Among their several suggestions is consideration of an alternative approach that substitutes low-dose drug treatment for placebo. This has become a rather common practice in Europe, but we believe it is associated with 2 substantial problems. To be effective in the scientific design, the low dose must be inferior treatment to the standard dose. To the extent that this is true, the same ethical issues that must be addressed regarding placebo are relevant. When the intent of the low dose is to provide a no-treatment control, it fails to alter either the safety or ethical considerations related to placebo-controlled studies. We are also concerned that to the extent the low dose is therapeutically effective, it undermines the scientific design and requires an ever-greater number of subjects to provide statistical power. We believe these issues merit much discussion and appreciate the informed commentary of these colleagues.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.